Rua Bioscience expands share base with employee performance allocation

Rua Bioscience Limited has issued 3,594,037 new ordinary shares as performance payments to employees. This allocation, effective September 19, 2025, represents 1.44% of the company's total ordinary shares and warrants on issue, calculated on the assumption that all outstanding warrants are vested and exercised. The shares were issued at NZ$0.00, with no cash payment involved, and rank equally with all other fully paid ordinary shares.

The strategic move aims to reward staff for past performance and incentivize future contributions. Following this issue, Rua Bioscience's total ordinary shares on issue now stand at 244,042,048, alongside 5,926,673 warrants. This capital change was authorized by a board resolution.

Paul Naske is the authorized contact person for this announcement, which was released on September 19, 2025.